FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to haematology, cardiology and endocrinology, and can be used for correction of the blood microvesicle level in the patients with dyslipidemia and abdominal obesity. That is ensured by individual hypocaloric diet, graduated physical activity and administration of preparation Lovastatin 40 mg once a day in the evening at mealtimes. The length of treatment is at least 10 weeks.
EFFECT: invention provides normalisation of the blood microvesicle level in the case patients that allows considerably lowering hemocoagulation potential of blood, reducing risk of thrombotic complications.
1 ex
Authors
Dates
2010-07-10—Published
2009-04-17—Filed